Cargando…
Clinical Implications of Methylenetetrahydrofolate Reductase Mutations and Plasma Homocysteine Levels in Patients with Thromboembolic Occlusion
PURPOSE: Hyperhomocysteinemia has been identified as an independent risk factor in arterial and venous thrombosis. Mutations in genes encoding methylenetetrahydrofolate reductase (MTHFR), involved in the metabolism of homocysteine, may account for reduced enzyme activity and elevated plasma homocyst...
Autores principales: | Park, Won-Cheol, Chang, Jeong-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Vascular Specialist International
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480315/ https://www.ncbi.nlm.nih.gov/pubmed/26217629 http://dx.doi.org/10.5758/vsi.2014.30.4.113 |
Ejemplares similares
-
Methylenetetrahydrofolate reductase polymorphisms and elevated plasma homocysteine levels in small vessel disease
por: Chen, Lei, et al.
Publicado: (2023) -
Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase Gene Mutation and Normal Homocysteine Levels
por: Ghumman, Ghulam Mujtaba, et al.
Publicado: (2021) -
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis
por: Li, Dan, et al.
Publicado: (2014) -
Methylenetetrahydrofolate reductase polymorphism in healthy volunteers and its correlation with homocysteine levels in patients with thrombosis
por: Munshi, Renuka, et al.
Publicado: (2019) -
Association of homocysteine and polymorphism of methylenetetrahydrofolate reductase with early-onset post stroke depression
por: Zhang, Jingyuan, et al.
Publicado: (2022)